Target intelligence / Profile preview

Iron-mediated free radical formation

Molecular classification
Other (chemical process involving transition metals and reactive oxygen species)
01

Overview

Iron-mediated free radical formation" refers to a chemical process rather than a discrete molecular target. It primarily involves the catalytic activity of ferrous iron (Fe2+) in the presence of hydrogen peroxide, leading to the production of highly reactive hydroxyl radicals via the Fenton reaction[1][2][3]. This process is central in oxidative stress biology because it can cause significant biomolecular damage—affecting lipids, proteins, and DNA—and is implicated in various pathological conditions including cancer, neurodegeneration, cardiovascular diseases, inflammation, and general tissue injury[2]. The biological significance arises from both endogenous metabolic processes and exogenous exposures that increase available redox-active iron or hydrogen peroxide. While not itself a druggable target like an enzyme or receptor protein, interventions often focus on limiting available catalytic iron through chelation therapy or reducing resultant oxidative damage with antioxidants[2][3]. Note: "Iron-mediated free radical formation" does not refer to a single molecule/receptor but rather describes a biochemical pathway/process. Therefore it should not be considered a canonical therapeutic target; this entry is best classified as incorrect for structured drug-target databases.

Other names
Fenton reactioniron-catalyzed free radical generationiron-induced oxidative stress
02

Mechanism of action

Chelation of iron to prevent redox cycling and free radical formation; Scavenging of generated radicals to reduce cellular damage.

03

Biological functions

Generation of reactive oxygen speciesOxidative stress inductionCellular damage mediationRedox cycling
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther (general tissue injury and aging)
05

Safety considerations

Disruption of essential iron-dependent processes if chelation is excessivePotential for increased infection risk with systemic iron depletion
06

Interacting drugs

Iron chelators (e.g., deferoxamine)

1 more in the full profile.

07

Biomarkers

Levels of malondialdehyde or 4-hydroxynonenal (lipid peroxidation products)

Beyond the preview

Go deeper on Iron-mediated free radical formation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-mediated free radical formation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call